The global burden of disease attributable to metabolic risks in 204 countries and territories from 1990 to 2019
W Hu, C Zhai, H Sun, XY Gong, L Cui, L Cai… - Diabetes Research and …, 2023 - Elsevier
Aim Our study aimed to survey the burden of disease attributed to metabolic risks (MRs) and
secondary MR from 1990 to 2019. Methods Using methodological framework of the Global …
secondary MR from 1990 to 2019. Methods Using methodological framework of the Global …
Impact of the COVID-19 pandemic on dental and medical education in Bangladesh: A pilot study and the implications
K Chowdhury, M Haque, AB Lutfor… - … Journal of Medical …, 2022 - strathprints.strath.ac.uk
Objective: Lockdown and other measures, including the closure of universities, introduced
by Governments across countries in response to the COVID-19 pandemic have appreciably …
by Governments across countries in response to the COVID-19 pandemic have appreciably …
Availability and use of long-acting insulin analogues including their biosimilars across Africa; findings and implications
B Godman, T Leong, AR Abubakar, A Kurdi… - Internal …, 2021 - pureportal.strath.ac.uk
Background: Prevalence rates of diabetes mellitus are growing across Africa with an
appreciable number likely to be on insulin to manage their condition. This has significant …
appreciable number likely to be on insulin to manage their condition. This has significant …
Utilisation Trend of Long‐Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications
B Godman, M Wladysiuk, S McTaggart… - BioMed research …, 2021 - Wiley Online Library
Background. Diabetes mellitus rates and associated costs continue to rise across Europe
enhancing health authority focus on its management. The risk of complications is enhanced …
enhancing health authority focus on its management. The risk of complications is enhanced …
Enhancing choices regarding the administration of insulin among patients with diabetes requiring insulin across countries and implications for future care
There are a number of ongoing developments to improve the care of patients with diabetes
across countries given its growing burden. Recent developments include new oral …
across countries given its growing burden. Recent developments include new oral …
Assessing the management of patients with type 2 diabetes in Bangladesh during pre-and post-COVID-19 era and the implications: A pilot study
There is growing concern with the management of patients with type 2 diabetes (T2DM)
across countries with suboptimal management increasing morbidity, mortality, and costs. In …
across countries with suboptimal management increasing morbidity, mortality, and costs. In …
Trends in the Cost of Medicines, Consultation Fees and Clinic Visits in Malaysia's Private Primary Healthcare System: Employer Health Insurance Coverage
CS Zin, NS Ab Rahman… - Journal of …, 2023 - Taylor & Francis
Objective To examine trends in the cost of medicines, consultation fees and clinic visits
among the employees covered by the employer health insurance in Malaysia's private …
among the employees covered by the employer health insurance in Malaysia's private …
Out-Of-Pocket Expenditure Associated with Physical Inactivity, Excessive Weight, and Obesity in China: Quantile Regression Approach
Y Zhao, L He, T Marthias, M Ishida, K Anindya… - Obesity Facts, 2022 - karger.com
Introduction: Previous studies exploring associations of physical inactivity, obesity, and out-
of-pocket expenditure (OOPE) mainly used traditional linear regression, and little is known …
of-pocket expenditure (OOPE) mainly used traditional linear regression, and little is known …
[PDF][PDF] Oral Antidiabetic Medications: Technical Notes
G Bereda - Journal of Diabetic Nephropathy and Diabetes …, 2022 - snipub.com
An oral antidiabetic medication is the first line of medicine treatment for type 2 diabetes
mellitus. Biguanides are ancient agents that function by declining hepatic glucose output …
mellitus. Biguanides are ancient agents that function by declining hepatic glucose output …
A cross-sectional study of quality of life among Brazilian adults with type 1 diabetes treated with insulin glargine: findings and implications
PHRF Almeida, B Godman… - Clinical …, 2022 - Am Diabetes Assoc
This article describes a cross-sectional study involving 401 adults with type 1 diabetes
treated with insulin glargine in Minas Gerais, Brazil. Health-related quality of life was …
treated with insulin glargine in Minas Gerais, Brazil. Health-related quality of life was …